Elizabeth A. Slee

5.8k total citations · 2 hit papers
28 papers, 4.8k citations indexed

About

Elizabeth A. Slee is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, Elizabeth A. Slee has authored 28 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 16 papers in Oncology and 5 papers in Biotechnology. Recurrent topics in Elizabeth A. Slee's work include Cancer-related Molecular Pathways (14 papers), Cell death mechanisms and regulation (11 papers) and Ubiquitin and proteasome pathways (6 papers). Elizabeth A. Slee is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), Cell death mechanisms and regulation (11 papers) and Ubiquitin and proteasome pathways (6 papers). Elizabeth A. Slee collaborates with scholars based in United Kingdom, Ireland and China. Elizabeth A. Slee's co-authors include Séamus J. Martin, Colin Adrain, Xin Lü, Donald W. Nicholson, Mary T. Harte, Carlos A. Casiano, Douglas R. Green, John C. Reed, Beni B. Wolf and Ruth M. Kluck and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Elizabeth A. Slee

28 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ordering the Cytochrome c–initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9–dependent Manner

1999 1.6k citations Elizabeth A. Slee, Mary T. Harte et al. The Journal of Cell Biology profile →
Executioner Caspase-3, -6, and -7 Perform Distinct, Non-redundant Roles during the Demolition Phase of Apoptosis

2001 894 citations Elizabeth A. Slee, Colin Adrain et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth A. Slee United Kingdom	17	3.6k	1.1k	755	593	543	28	4.8k
Jürgen Eberle Germany	39	2.7k 0.8×	1.1k 1.0×	858 1.1×	746 1.3×	524 1.0×	125	4.9k
Solange Desagher France	18	4.0k 1.1×	672 0.6×	645 0.9×	631 1.1×	447 0.8×	23	5.1k
Colin Adrain United Kingdom	25	3.1k 0.9×	738 0.7×	888 1.2×	581 1.0×	404 0.7×	44	4.4k
Markus Loeffler Germany	15	4.0k 1.1×	727 0.7×	840 1.1×	709 1.2×	403 0.7×	24	5.4k
Hans Kristian Lorenzo France	18	4.5k 1.3×	765 0.7×	849 1.1×	815 1.4×	514 0.9×	33	6.0k
John C. Reed United States	12	3.8k 1.1×	1.0k 1.0×	789 1.0×	386 0.7×	637 1.2×	13	5.0k
Ambereen Ali United States	10	3.3k 0.9×	884 0.8×	789 1.0×	334 0.6×	522 1.0×	13	4.5k
Hideki Sakahira Japan	18	4.6k 1.3×	757 0.7×	1.1k 1.5×	514 0.9×	524 1.0×	21	5.7k
Violeta Yu United States	15	3.2k 0.9×	768 0.7×	774 1.0×	327 0.6×	483 0.9×	29	4.4k
Andrea J. Ross United States	14	3.7k 1.0×	751 0.7×	748 1.0×	711 1.2×	446 0.8×	15	4.9k

Countries citing papers authored by Elizabeth A. Slee

Since Specialization

Citations

This map shows the geographic impact of Elizabeth A. Slee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Slee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Slee more than expected).

Fields of papers citing papers by Elizabeth A. Slee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth A. Slee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Slee. The network helps show where Elizabeth A. Slee may publish in the future.

Co-authorship network of co-authors of Elizabeth A. Slee

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth A. Slee. A scholar is included among the top collaborators of Elizabeth A. Slee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth A. Slee. Elizabeth A. Slee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Akama‐Garren, Elliot H., Paul Miller, Thomas Carroll, et al.. (2023). Regulation of immunological tolerance by the p53-inhibitor iASPP. Cell Death and Disease. 14(2). 84–84. 6 indexed citations

Miller, Paul, Elliot H. Akama‐Garren, Richard Owen, et al.. (2023). p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer. Cell Death and Differentiation. 30(7). 1619–1635. 5 indexed citations

He, Min, Elizabeth A. Slee, Mengmeng Sun, et al.. (2022). Defect in Ser312 phosphorylation of Tp53 dysregulates lipid metabolism for fatty accumulation and fatty liver susceptibility: Revealed by lipidomics. Journal of Chromatography B. 1211. 123491–123491. 1 indexed citations

Sutendra, Gopinath, Ying Hu, Elizabeth A. Slee, et al.. (2018). Cell autonomous role of iASPP deficiency in causing cardiocutaneous disorders. Cell Death and Differentiation. 25(7). 1289–1303. 12 indexed citations

Hu, Ying, Wenjie Ge, Xingwen Wang, et al.. (2015). Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB. Oncotarget. 6(40). 42478–42490. 17 indexed citations

Godin-Heymann, Nadia, Yihua Wang, Elizabeth A. Slee, & Xin Lü. (2013). Phosphorylation of ASPP2 by RAS/MAPK Pathway Is Critical for Its Full Pro-Apoptotic Function. PLoS ONE. 8(12). e82022–e82022. 13 indexed citations

Slee, Elizabeth A. & Xin Lü. (2011). In the right place at the right time: Analysis of p53 serine 312 phosphorylation in vivo. Cell Cycle. 10(9). 1345–1346. 1 indexed citations

Slee, Elizabeth A., Barbara Benassi, Robert Goldin, et al.. (2010). Phosphorylation of Ser312 contributes to tumor suppression by p53 in vivo. Proceedings of the National Academy of Sciences. 107(45). 19479–19484. 18 indexed citations

Slee, Elizabeth A., et al.. (2008). A complex barcode underlies the heterogeneous response of p53 to stress. Nature Reviews Molecular Cell Biology. 9(9). 702–712. 334 indexed citations

10.

Vives, Virginie, Shan Zhong, Indrika Ratnayaka, et al.. (2006). ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth. Genes & Development. 20(10). 1262–1267. 80 indexed citations

11.

Vives, Virginie, Elizabeth A. Slee, & Xin Lü. (2006). ASPP2: A Gene that Controls Life and Death in Vivo. Cell Cycle. 5(19). 2187–2190. 22 indexed citations

12.

Slee, Elizabeth A., Daniel O’Connor, & Xin Lü. (2004). To die or not to die: how does p53 decide?. Oncogene. 23(16). 2809–2818. 218 indexed citations

13.

Slee, Elizabeth A., Sébastien Gillotin, Daniele Bergamaschi, et al.. (2004). The N-terminus of a novel isoform of human iASPP is required for its cytoplasmic localization. Oncogene. 23(56). 9007–9016. 48 indexed citations

14.

Slee, Elizabeth A.. (2003). The ASPP family: deciding between life and death after DNA damage. Toxicology Letters. 139(2-3). 81–87. 35 indexed citations

15.

Slee, Elizabeth A., Colin Adrain, & Séamus J. Martin. (2001). Executioner Caspase-3, -6, and -7 Perform Distinct, Non-redundant Roles during the Demolition Phase of Apoptosis. Journal of Biological Chemistry. 276(10). 7320–7326. 894 indexed citations breakdown →

16.

Eléouët, Jean‐François, Elizabeth A. Slee, Françoise Saurini, et al.. (2000). The Viral Nucleocapsid Protein of Transmissible Gastroenteritis Coronavirus (TGEV) Is Cleaved by Caspase-6 and -7 during TGEV-Induced Apoptosis. Journal of Virology. 74(9). 3975–3983. 79 indexed citations

17.

Chow, Sek C., Elizabeth A. Slee, Marion MacFarlane, & Gerald M. Cohen. (1999). Caspase-1 Is Not Involved in CD95/Fas-Induced Apoptosis in Jurkat T Cells. Experimental Cell Research. 246(2). 491–500. 17 indexed citations

18.

Adrain, Colin, Elizabeth A. Slee, Mary T. Harte, & Séamus J. Martin. (1999). Regulation of Apoptotic Protease Activating Factor-1 Oligomerization and Apoptosis by the WD-40 Repeat Region. Journal of Biological Chemistry. 274(30). 20855–20860. 98 indexed citations

19.

Slee, Elizabeth A., Mary T. Harte, Ruth M. Kluck, et al.. (1999). Ordering the Cytochrome c–initiated Caspase Cascade: Hierarchical Activation of Caspases-2, -3, -6, -7, -8, and -10 in a Caspase-9–dependent Manner. The Journal of Cell Biology. 144(2). 281–292. 1648 indexed citations breakdown →

20.

Slee, Elizabeth A., et al.. (1995). Overcoming Polymerase Chain Reaction Inhibition in Old Animal Tissue Samples Using Ethidium Bromide. Analytical Biochemistry. 225(1). 169–172. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact